Sun Pharma Announces US Launch of Authorized Generic for Welchol® Tablets


Mumbai– Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) today announced that one of its wholly owned subsidiaries has launched in US, the Authorized Generic (AG) version for Daiichi Sankyo Inc.’s Welchol® (colesevelam hydrochloride) 625mg tablets.

The launch is pursuant to a distribution and supply agreement between Sun Pharma’s wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period. Welchol® Tablets recorded US sales of approximately US$ 520 million for the 12 months ending March 2018, as per IQVIA.





Leave A Reply

six − 4 =